Skip to main content

Percutaneous Transvenous Mitral Commissurotomy (PTMC) - Opening Hearts, Restoring Hope

 


Healing Hearts, Restoring Rhythm: A Step-by-Step Guide to Percutaneous Transvenous Mitral Commissurotomy (PTMC)


Keywords: PTMC, mitral stenosis, heart valve disease, minimally invasive procedure, interventional cardiology

Introduction:

Mitral stenosis, a narrowing of the mitral valve opening, affects millions worldwide, causing symptoms like shortness of breath, fatigue, and palpitations. Percutaneous Transvenous Mitral Commissurotomy (PTMC) is a minimally invasive procedure that offers a life-changing solution for these patients. In this article, we'll delve into the world of PTMC, explaining the step-by-step process and shedding light on this remarkable treatment option.

What is PTMC?

PTMC is a non-surgical procedure used to treat mitral stenosis. It involves using a balloon catheter to widen the narrowed mitral valve, restoring normal blood flow and alleviating symptoms.

Step-by-Step Guide to PTMC:

Step 1: Preparation

Patients undergo thorough evaluation, including echocardiography, ECG, and blood tests.
Fasting and medication instructions are provided.
Informed consent is obtained.

Step 2: Access and Catheterization

Local anesthesia is administered, and a small incision is made in the femoral vein (groin area).
A guidewire and introducer sheath are inserted, followed by a balloon catheter.
The catheter is advanced through the vein, guided by fluoroscopy and echocardiography.

Step 3: Crossing the Mitral Valve

The balloon catheter is carefully maneuvered across the mitral valve.
A specialized catheter, called a "Brockenbrough needle," may be used to help cross the valve.

Step 4: Balloon Inflation

The balloon catheter is inflated with a contrast agent, allowing visualization of the valve.
The balloon is gradually inflated to widen the valve opening.

Step 5: Commissurotomy

The inflated balloon is used to split the fused commissures (valve leaflets).
The valve opening is enlarged, restoring normal blood flow.

Step 6: Balloon Deflation and Removal

The balloon is deflated, and the catheter is removed.
The introducer sheath is also removed, and the incision site is closed.

Step 7: Post-Procedure Care

Patients are monitored for several hours to ensure stability.
Echocardiography and ECG are performed to assess the procedure's success.
Patients are advised to rest and avoid heavy lifting or strenuous activities.

Benefits and Risks:

PTMC offers numerous benefits, including:

Minimally invasive, reducing recovery time and scarring
High success rate in improving symptoms and valve function
Low risk of complications compared to surgical alternatives

However, as with any medical procedure, risks and potential complications exist:

Bleeding or hematoma at the access site
Infection or sepsis
Valve damage or regurgitation
Stroke or transient ischemic attack

Conclusion:

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is a remarkable treatment option for patients with mitral stenosis. By understanding the step-by-step process and benefits of PTMC, patients and healthcare professionals can make informed decisions about this life-changing procedure. If you or someone you know is living with mitral stenosis, consult with a healthcare professional to discuss the potential of PTMC in restoring heart rhythm and improving quality of life.


Labels:

Comments

Post a Comment

Drop your thoughts here, we would love to hear from you

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...
Post a Comment
Latest Posts »

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.
1 comment
Latest Posts »

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...
Post a Comment
Latest Posts »